Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Sarizotan hydrochloride

EU orphan designation number: EU/3/15/1531   
Active ingredient: Sarizotan hydrochloride
Indication: Treatment of Rett syndrome
Sponsor: Newron Pharmaceuticals SpA
Via Lodovico Aristo, 20091 Bresso, Milan, Italy

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/07/2015 Orphan designation EMA/OD/058/15 (2015)5441 of 28/07/2015